13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Madiha Derouazi

Founder and CEO
SwitzerlandAMAL Therapeutics

Madiha Derouazi has been working on vector engineering and therapeutic cancer vaccines for over 12 years. She has a strong background in applied molecular and cellular biotechnology, with research interests at the interface of fundamental and translational research. Madiha Derouazi holds a PhD in Biotechnology from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland and a Master in Biotechnology Engineering from the University of Technology of Berlin, Germany.

Scroll to Top
  • No products in the cart.